[
  {
    "ts": null,
    "headline": "AbbVie (NYSE:ABBV) Faces Legal Scrutiny Over Merger With Cerevel",
    "summary": "AbbVie (NYSE:ABBV) experienced a 6.8% share price increase over the past month, coinciding with several significant corporate events. The company announced a collaboration with ADARx Pharmaceuticals to develop siRNA therapeutics, as well as FDA approval for EMRELIS™ in treating lung cancer, indicating strong product development. Additionally, AbbVie's stock buyback activity and board expansion added layers of positive momentum. Although the markets experienced a 1.1% decline driven by broader...",
    "url": "https://finnhub.io/api/news?id=b75a74939a9ca108beffb6d578fcce8dd5d49d490dda335b766eb87fffbfdb78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747936120,
      "headline": "AbbVie (NYSE:ABBV) Faces Legal Scrutiny Over Merger With Cerevel",
      "id": 134658450,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE:ABBV) experienced a 6.8% share price increase over the past month, coinciding with several significant corporate events. The company announced a collaboration with ADARx Pharmaceuticals to develop siRNA therapeutics, as well as FDA approval for EMRELIS™ in treating lung cancer, indicating strong product development. Additionally, AbbVie's stock buyback activity and board expansion added layers of positive momentum. Although the markets experienced a 1.1% decline driven by broader...",
      "url": "https://finnhub.io/api/news?id=b75a74939a9ca108beffb6d578fcce8dd5d49d490dda335b766eb87fffbfdb78"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient",
    "summary": "AbbVie (NYSE: ABBV) in partnership with the University of Toronto's SpinUp, are pleased to announce Neuropeutics Inc as the recipient of the AbbVie Biotech Innovators Award, a national prize to help foster innovation and support growth in Canada's life sciences sector. Following a competitive selection process, the award, funded by AbbVie, has been granted to Neuropeutics Inc for developing small molecules preventing and reversing protein aggregation as therapeutics for neurodegenerative disease",
    "url": "https://finnhub.io/api/news?id=a58edbacee81018f77561ad6ba73467aff78c5c06cfb409bf9d037d227824016",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747926000,
      "headline": "AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient",
      "id": 134658451,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) in partnership with the University of Toronto's SpinUp, are pleased to announce Neuropeutics Inc as the recipient of the AbbVie Biotech Innovators Award, a national prize to help foster innovation and support growth in Canada's life sciences sector. Following a competitive selection process, the award, funded by AbbVie, has been granted to Neuropeutics Inc for developing small molecules preventing and reversing protein aggregation as therapeutics for neurodegenerative disease",
      "url": "https://finnhub.io/api/news?id=a58edbacee81018f77561ad6ba73467aff78c5c06cfb409bf9d037d227824016"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie (ABBV) has a Stable and Highly Profitable Business Model",
    "summary": "Renaissance Investment Management, an investment management company, released its Q1 2025 “Large Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The S&P 500 experienced a 4.3% loss in Q1 due to uncertainty in technology stock valuations and US economic policies. However, seven sectors showed positive returns, with Energy, Health […]",
    "url": "https://finnhub.io/api/news?id=b161730f75c325d43f675c799e98bdf1a30768ab07a69fe412a7e718d02354d5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747918362,
      "headline": "AbbVie (ABBV) has a Stable and Highly Profitable Business Model",
      "id": 134658452,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Renaissance Investment Management, an investment management company, released its Q1 2025 “Large Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The S&P 500 experienced a 4.3% loss in Q1 due to uncertainty in technology stock valuations and US economic policies. However, seven sectors showed positive returns, with Energy, Health […]",
      "url": "https://finnhub.io/api/news?id=b161730f75c325d43f675c799e98bdf1a30768ab07a69fe412a7e718d02354d5"
    }
  },
  {
    "ts": null,
    "headline": "How To Build A $1,000 Monthly Stable Dividend Income",
    "summary": "How To Build A $1,000 Monthly Stable Dividend Income",
    "url": "https://finnhub.io/api/news?id=532dbb1610b3f3a6326424b6d57c2fa13eb91826dcfd11d7b77fb81ae984ba22",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747899024,
      "headline": "How To Build A $1,000 Monthly Stable Dividend Income",
      "id": 134647731,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=532dbb1610b3f3a6326424b6d57c2fa13eb91826dcfd11d7b77fb81ae984ba22"
    }
  },
  {
    "ts": null,
    "headline": "Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - ABBV",
    "summary": "NEW YORK, May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. . ...",
    "url": "https://finnhub.io/api/news?id=05dd3fdcd7cf6e3918cdcb572ce426aac83961d246b2e1bea763d9d089431232",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747892776,
      "headline": "Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - ABBV",
      "id": 134646886,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "NEW YORK, May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. . ...",
      "url": "https://finnhub.io/api/news?id=05dd3fdcd7cf6e3918cdcb572ce426aac83961d246b2e1bea763d9d089431232"
    }
  },
  {
    "ts": null,
    "headline": "3 Value Stocks Facing Headwinds",
    "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
    "url": "https://finnhub.io/api/news?id=2da0c271d35392f268bb4c87ad92698a63e65636420a9fdc7115b90375d5706f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747888509,
      "headline": "3 Value Stocks Facing Headwinds",
      "id": 134647936,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
      "url": "https://finnhub.io/api/news?id=2da0c271d35392f268bb4c87ad92698a63e65636420a9fdc7115b90375d5706f"
    }
  }
]